Regulation of mouse Heparanase gene expression in T lymphocytes and tumor cells

Immunology and Cell Biology

Volumn 85, Issue 3, 2007, Pages 205-214

  De Mestre, Amanda M ^a,b   Soe Htwe, Thura ^a   Sutcliffe, Elissa L ^a   Rao, Sudha ^a   Pagler, Eloisa B ^a   Hornby, June R ^a   Hulett, Mark D ^a  

^a Australian National University   (Australia)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Chromatin remodeling; Early growth response gene 1; Gene regulation; Heparanase; Transcription

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; HEPARANASE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MELANOMA CELL; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PROMOTER REGION; REGULATORY SEQUENCE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONIDASE; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

ANIMALIA;

EID: 34247855903     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100022     Document Type: Article

References (51)

1. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001; 1471: M99-M108.
2. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001; 108: 341-347.
3. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I et al. Heparanase as mediator of angiogenesis: mode of action. Faseb J 2001; 15: 1661-1663.
4. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 2004; 96: 1219-1230.
5. Rohloff J, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mossner J et al. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer 2002; 86: 1270-1275.
6. Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 2003; 63: 8749-8756.
7. Maxhimer JB, Quiros RM, Stewart R, Dowlatshahi K, Gattuso P, Fan M et al. Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery 2002; 132: 326-333.
8. Takaoka M, Naomoto Y, Ohkawa T, Uetsuka H, Shirakawa Y, Uno F et al. Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab Invest 2003; 83: 613-622.
9. Jiang P, Kumar A, Parrillo JE, Dempsey LA, Platt JL, Prinz RA et al. Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem 2002; 277: 8989-8998.
10. Lu WC, Liu YN, Kang BB, Chen JH. Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 2003; 22: 919-923.
11. de Mestre AM, Khachigian LM, Santiago FS, Staykova MA, Hulett MD. Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem 2003; 278: 50377-50385.
12. de Mestre AM, Rao S, Hornby JR, Soe-Htwe T, Khachigian LM, Hulett MD. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells. J Biol Chem 2005; 280: 35136-35147.
13. Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I. Tumor suppressor p53 regulates heparanase gene expression. Oncogene 2006; 25: 3939-3947.
14. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, Rosier RN. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 2000; 60: 6557-6562.
15. Miao HQ, Navarro E, Patel S, Sargent D, Koo H, Wan H et al. Cloning, expression, and purification of mouse heparanase. Protein Exp Purif 2002; 26: 425-431.
16. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992; 12: 112-127.
17. Bashkin P, Razin E, Eldor A, Vlodavsky I. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 1990; 75: 2204-2212.
18. Marchetti D, Li J, Shen R. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Cancer Res 2000; 60: 4767-4770.
19. Irony-Tur-Sinai M, Vlodavsky I, Ben-Sasson SA, Pinto F, Sicsic C, Brenner T. A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammation. J Neurol Sci 2003; 206: 49-57.
20. Saijo M, Kitazawa R, Nakajima M, Kurosaka M, Maeda S, Kitazawa S. Heparanase mRNA expression during fracture repair in mice. Histochem Cell Biol 2003; 120: 493-503.
21. Marchetti D, Menter D, Jin L, Nakajima M, Nicolson GL. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993; 55: 692-699.
22. Nakajima M, Irimura T, Di Ferrante N, Nicolson GL. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 1984; 259: 2283-2290.
23. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999; 5: 803-809.
24. Dong J, Kukula AK, Toyoshima M, Nakajima M. Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene 2000; 253: 171-178.
25. Dempsey LA, Plummer TB, Coombes SL, Platt JL. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 2000; 10: 467-475.
26. Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP et al. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 1999; 261: 183-187.
27. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999; 5: 793-802.
28. Chen G, Wang D, Vikramadithyan R, Yagyu H, Saxena U, Pillarisetti S et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry 2004; 43: 4971-4977.
29. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431.
30. Shteper PJ, Zcharia E, Ashhab Y, Peretz T, Vlodavsky I, Ben-Yehuda D. Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene 2003; 22: 7737-7749.
31. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-4884.
32. Khachigian LM, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 457-461.
33. Arney KL, Fisher AG. Epigenetic aspects of differentiation. J Cell Sci 2004; 117 (Part 19): 4355-4363.
34. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2002; 2: 162-174.
35. Kioussis D, Ellmeier W. Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation. Nat Rev Immunol 2002; 2: 909-919.
36. Smale ST, Fisher AG. Chromatin structure and gene regulation in the immune system. Annu Rev Immunol 2002; 20: 427-462.
37. Ward SB, Hernandez-Hoyos G, Chen F, Waterman M, Reeves R, Rothenberg EV. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res 1998; 26: 2923-2934.
38. Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci USA 1993; 90: 2466-2470.
39. Rao S, Procko E, Shannon MF. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J Immunol 2001; 167: 4494-4503.
40. Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026-1032.
41. Khachigian LM, Williams AJ, Collins T. Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem 1995; 270: 27679-27686.
42. Yu J, de Belle I, Liang H, Adamson ED. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell 2004; 15: 83-94.
43. Simizu S, Ishida K, Osada H. Heparanase as a molecular target of cancer chemotherapy. Cancer Sci 2004; 95: 553-558.
44. Ogishima T, Shiina H, Breault JE, Tabatabai L, Bassett WW, Enokida H et al. Increased heparanase expression is caused by promoter hypomethylation and upregulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res 2005; 11: 1028-1036.
45. Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M et al. Transactivation of the EGR1 gene contributes to mutant p53 gain of function. Cancer Res 2004; 64: 8318-8327.
46. Zipfel PF, Decker EL, Holst C, Skerka C. The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor. Biochim Biophys Acta 1997; 1354: 134-144.
47. Tourtellotte WG, Nagarajan R, Bartke A, Milbrandt J. Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis. Mol Cell Biol 2000; 20: 5261-5268.
48. Murtagh J, Martin F, Gronostajski RM. The Nuclear Factor I (NFI) gene family in mammary gland development and function. J Mammary Gland Biol Neoplasia 2003; 8: 241-254.
49. Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene 2000; 249: 31-45.
50. Novak TJ, White PM, Rothenberg EV. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res 1990; 18: 4523-4533.
51. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.